<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231106059970N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-19</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effectiveness of four transdiagnostic among adults and adolescences</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effectiveness of four transdiagnostic treatments on reduction of symptoms of emotional disorders and Cluster B personality disorders among adults and adolescences</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>360</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73577</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The G*Power software will be used for calculating sample size by indicating the margin of error of 0.05 and power of 0.95 total sample size will be 180 for adolescent and 180for adult sample size. 180 participants of adolescents will be randomly allocated in four groups by using https://www.dcode.fr/random-selection and after that each group will received one of the treatments randomly. this will be done for adult group, too, Blinding description: In the current study, participants will received a code for registering in study, after allocation randomly in treatment groups, therapists who will be blinded to participants diagnosis, will apply treatments. After intervention finish, the  
assessors who will be blind to participants diagnosis and type of intervention will analysis data. Finally, the observer, the only person who know who receive which treatment will write the report.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Individuals who meet the full criteria of emotional disorders including mood disorders,  anxiety disorders, OCD, PTSD,and eating disorder. Condition 2: Individuals who meet the full criteria of emotional disorders including mood disorders,  anxiety disorders, OCD, PTSD, and eating disorders. Condition 3: Individuals who meet the full criteria of emotional disorders including mood disorders,  anxiety disorders, OCD, PTSD, and eating disorders. Condition 4: Individuals who meet the full criteria of emotional disorders including mood disorders,  anxiety disorders, OCD, PTSD,and eating disorders. Condition 5: Individuals who meet the full criteria of emotional disorders including mood disorders,  anxiety disorders, OCD, PTSD, and eating disorders. Condition 6: Individuals who meet the full criteria of cluster B personality disorders consists of antisocial personality disorder, borderline personality disorder, narcissistic personality. Condition 7: Individuals who meet the full criteria of cluster B personality disorders consists of antisocial personality disorder, borderline personality disorder, narcissistic personality. Condition 8: Individuals who meet the full criteria of cluster B personality disorders consists of antisocial personality disorder, borderline personality disorder, narcissistic personality. Condition 9: Individuals who meet the full criteria of cluster B personality disorders consists of antisocial personality disorder, borderline personality disorder, narcissistic personality.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Adaptation of Unified protocol for adolescents  which consists 8 - 15weekly45-60 minutes session. Primary care-giver can participate in this treatment weekly either 2-5 individuals sessions. Intervention 2: Intervention group: Unified protocol consists 8-14 weekly session that last between 45-60 minutes. main modules based on each participants conceptualization will be applied. Intervention 3: Intervention group: Modified Dialectical behaviour therapy (DBT) for adolescents consists of weekly individual therapy sessions (approximately 1 hour), a weekly group skills training session (approximately 1.5–2.5 hours), and a therapist consultation team meeting (approximately 1–2 hours) that can last for 20 sessions. Intervention 4: Intervention group: Dialectical behaviour therapy (DBT)The standard DBT treatment package consists of weekly individual therapy sessions (approximately 1 hour), a weekly group skills training session (approximately 1.5–2.5 hours), and a therapist consultation team meeting (approximately 1–2 hours). Intervention 5: Intervention group: Modified mentalization-based treatment for adolescents (MBT-A) is a manualized, psychodynamic psychotherapy based on attachment theory . It consists of 50 minutes of individual weekly and family monthly sessions and lasts for one -year. Intervention 6: Intervention group: Mentalization-based treatment for adults is a manualized, psychodynamic psychotherapy based on attachment theory . It consists of 50 minutes of individual weekly and family monthly sessions and lasts for one -year. Intervention 7: Intervention group: َmodification version of Self-Acceptance Group Therapy (SAGT) is 12, 90-minute weekly sessions and will be applied in small groups of six participants and focuses on shame, acceptance and emotion regulation. Intervention 8: Intervention group: Self-Acceptance Group Therapy (SAGT) is 12, 90-minute weekly sessions and will be applied in small groups of six participants and focuses on shame, acceptance and emotion regulation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is for reasonable requests the data will be shared</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Banafsheh Mohajerin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>psychology department,4 floor, taleqani Hospiotal, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 912 578 6918</telephone>
        <email>banafshehmohajerin@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>banafsheh mohajerin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Psychology department, 4ّFloor, Taleqani Hospital, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 912 578 6918</telephone>
        <email>banafshehmohajerin@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 11-18 in adolescence sample
Age between 18 to 65 in adults group
Be able to read and speak Farsi fluently,
participant in in-person psychotherapy sessions
Adolescence sample meet full criteria for at least one emotional disorders
In Adult sample: meet full criteria for at least one emotional disorders and /or cluster B personality disorders</inclusion_criteria>
      <agemin>11 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>active suicidal plan
substance dependency,
meet criteria as schizophrenia and neurological diseases
psychiatry medicines
miss more than three psychotherapy session repeatedly</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F33</hc_code>
      <hc_code>F41.1</hc_code>
      <hc_code>F42</hc_code>
      <hc_code>F43.1</hc_code>
      <hc_code>F50</hc_code>
      <hc_code>F60.2</hc_code>
      <hc_code>F60.3</hc_code>
      <hc_code>F60.81</hc_code>
      <hc_code>F60.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, recurrent</hc_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
      <hc_keyword>Obsessive-compulsive disorder</hc_keyword>
      <hc_keyword>Post-traumatic stress disorder (PTSD)</hc_keyword>
      <hc_keyword>Eating disorders</hc_keyword>
      <hc_keyword>Antisocial personality disorder</hc_keyword>
      <hc_keyword>Borderline personality disorder</hc_keyword>
      <hc_keyword>Narcissistic personality disorder</hc_keyword>
      <hc_keyword>Histrionic personality disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Adaptation of Unified protocol for adolescents  which consists 8 - 15weekly45-60 minutes session. Primary care-giver can participate in this treatment weekly either 2-5 individuals sessions</i_keyword>
      <i_keyword>Intervention group: Unified protocol consists 8-14 weekly session that last between 45-60 minutes. main modules based on each participants conceptualization will be applied</i_keyword>
      <i_keyword>Intervention group: Modified Dialectical behaviour therapy (DBT) for adolescents consists of weekly individual therapy sessions (approximately 1 hour), a weekly group skills training session (approximately 1.5–2.5 hours), and a therapist consultation team meeting (approximately 1–2 hours) that can last for 20 sessions</i_keyword>
      <i_keyword>Intervention group: Dialectical behaviour therapy (DBT)The standard DBT treatment package consists of weekly individual therapy sessions (approximately 1 hour), a weekly group skills training session (approximately 1.5–2.5 hours), and a therapist consultation team meeting (approximately 1–2 hours)</i_keyword>
      <i_keyword>Intervention group: Modified mentalization-based treatment for adolescents (MBT-A) is a manualized, psychodynamic psychotherapy based on attachment theory . It consists of 50 minutes of individual weekly and family monthly sessions and lasts for one -year.</i_keyword>
      <i_keyword>Intervention group: Mentalization-based treatment for adults is a manualized, psychodynamic psychotherapy based on attachment theory . It consists of 50 minutes of individual weekly and family monthly sessions and lasts for one -year.</i_keyword>
      <i_keyword>Intervention group: َmodification version of Self-Acceptance Group Therapy (SAGT) is 12, 90-minute weekly sessions and will be applied in small groups of six participants and focuses on shame, acceptance and emotion regulation</i_keyword>
      <i_keyword>Intervention group: Self-Acceptance Group Therapy (SAGT) is 12, 90-minute weekly sessions and will be applied in small groups of six participants and focuses on shame, acceptance and emotion regulation</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Scores of Beck's Depression Inventory (BDI-II). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's Depression Inventory (BDI-II).</prim_outcome>
      <prim_outcome>Scores of  Beck's anxiety Inventory (BAI). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's anxiety Inventory (BAI).</prim_outcome>
      <prim_outcome>Scores of the Difficulties in Emotion Regulation Scale (DERS; Gratz &amp; Roemer, 2004). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Difficulties in Emotion Regulation Scale (DERS; Gratz &amp; Roemer, 2004).</prim_outcome>
      <prim_outcome>Scores of the Positive and Negative Affect Schedule (PANAS). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Positive and Negative Affect Schedule (PANAS) (Watson, Clark, &amp; Tellegen, 1988).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Scores of Shame severity. Timepoint: baseline, post- treatment, 6,12,18,24 and 36 months follow-up. Method of measurement: The Experience of Shame Scale (ESS, Andrews et al, 2002).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-29</approval_date>
        <contact_name>Research Ethics Committees of Vice-Chancellor in Research Affairs - Shahid Beheshti University of Me</contact_name>
        <contact_address>Ethic commitee of Shahid Beheshti University of Medical Sciences, 6 floor, 2th Building, Arabi St, Velenjak,Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
